This study is a prospective randomized trial of telemedicine (TM) versus face-to-face (F2F) visits for follow up care of patients with either early-stage breast or prostate cancer.~This study does not involve investigational drugs or devices but does involve survey data collection from participants about their experiences of care.~After an initial in-person routine visit, participants will be randomly assigned to either telemedicine or face-to-face care delivery for their next routine visit.~It is anticipated participants will be in the study for about 6 months depending on the timing of their routine care appointments.~It is expected that 360 people will take part in this research study
This research study is comparing telemedicine and face-to-face visits to understand patients' experiences with telemedicine versus face to face visits and to understand when it is and is not appropriate to conduct visits remotely